Moreover, regardless of adjustment for confounders or not, the prevalence of CHD was markedly increased in the high and intermediate Lp(a) groups, while Lp(a) levels were not evidently linked to CVL or diabetic microvascular complications including nephropathy, retinopathy and neuropathy. The gene discussed is LPA; the disease is kidney disorder.